Bicycle Therapeutics (BCYC) Revenue (2018 - 2025)
Historic Revenue for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $11.7 million.
- Bicycle Therapeutics' Revenue rose 33849.03% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 19415.63%. This contributed to the annual value of $1.2 million for FY2024, which is 7735.85% down from last year.
- Latest data reveals that Bicycle Therapeutics reported Revenue of $11.7 million as of Q3 2025, which was up 33849.03% from $2.9 million recorded in Q2 2025.
- Bicycle Therapeutics' Revenue's 5-year high stood at $11.7 million during Q3 2025, with a 5-year trough of -$30.4 million in Q4 2024.
- Over the past 5 years, Bicycle Therapeutics' median Revenue value was $4.3 million (recorded in 2021), while the average stood at $2.9 million.
- As far as peak fluctuations go, Bicycle Therapeutics' Revenue surged by 95000.0% in 2022, and later crashed by 29458.33% in 2023.
- Bicycle Therapeutics' Revenue (Quarter) stood at $800000.0 in 2021, then surged by 950.0% to $8.4 million in 2022, then crashed by 294.58% to -$16.3 million in 2023, then plummeted by 85.79% to -$30.4 million in 2024, then soared by 138.64% to $11.7 million in 2025.
- Its Revenue was $11.7 million in Q3 2025, compared to $2.9 million in Q2 2025 and $10.0 million in Q1 2025.